Quantcast

Subscribe to:
POZ magazine
E-newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:
Welcome, Guest. Please login or register.
July 30, 2014, 02:10:42 PM

Login with username, password and session length


Members
Stats
  • Total Posts: 632395
  • Total Topics: 47892
  • Online Today: 294
  • Online Ever: 585
  • (January 07, 2014, 02:31:47 PM)
Users Online

Welcome


Welcome to the POZ/AIDSmeds Community Forums, a round-the-clock discussion area for people with HIV/AIDS, their friends/family/caregivers, and others concerned about HIV/AIDS.  Click on the links below to browse our various forums; scroll down for a glance at the most recent posts; or join in the conversation yourself by registering on the left side of this page.

Privacy Warning:  Please realize that these forums are open to all, and are fully searchable via Google and other search engines. If you are HIV positive and disclose this in our forums, then it is almost the same thing as telling the whole world (or at least the World Wide Web). If this concerns you, then do not use a username or avatar that are self-identifying in any way. We do not allow the deletion of anything you post in these forums, so think before you post.

  • The information shared in these forums, by moderators and members, is designed to complement, not replace, the relationship between an individual and his/her own physician.

  • All members of these forums are, by default, not considered to be licensed medical providers. If otherwise, users must clearly define themselves as such.

  • Forums members must behave at all times with respect and honesty. Posting guidelines, including time-out and banning policies, have been established by the moderators of these forums. Click here for “Am I Infected?” posting guidelines. Click here for posting guidelines pertaining to all other POZ/AIDSmeds community forums.

  • We ask all forums members to provide references for health/medical/scientific information they provide, when it is not a personal experience being discussed. Please provide hyperlinks with full URLs or full citations of published works not available via the Internet. Additionally, all forums members must post information which are true and correct to their knowledge.

  • Product advertisement—including links; banners; editorial content; and clinical trial, study or survey participation—is strictly prohibited by forums members unless permission has been secured from POZ.

To change forums navigation language settings, click here (members only), Register now

Para cambiar sus preferencias de los foros en español, haz clic aquí (sólo miembros), Regístrate ahora

Finished Reading This? You can collapse this or any other box on this page by clicking the symbol in each box.

Author Topic: Overlapping Peptide treatment status, anyone have time to investegate  (Read 1549 times)

0 Members and 1 Guest are viewing this topic.

Offline bimazek

  • Member
  • Posts: 781
Scientists Make Breakthrough Discovery of New Technique to Fight HIV
   PDF     Print     E-mail
Written by Administrator|  28 February, 2005  18:29 GMT

HIV immunity breakthrough
The ability to induce and expand the immune response across most or all parts of the virus is highly advantageous. Our results, which consistently demonstrated sharply enhanced immunity in vaccinated animals, suggest that this therapy could also work in humans. A novel, simple and safe technique can boost the body’s immune response to deadly viruses like HIV and is even effective against drug resistant forms of the disease, Australian researchers have discovered.

The findings hold great promise for the treatment of HIV, other chronic viral infections, and drug resistant infections -- which are becoming a major problem, says Associate Professor Stephen Kent from the University of Melbourne’s Department of Microbiology and Immunology.

“We have invented a simple new technology to boost the ability of the immune system to fight chronic infections, such as AIDS and Hepatitis C, Associate Professor Kent says. "This involves using a patient’s own blood treated with small overlapping proteins of the virus [called peptides].”

The research will be published today in the Journal of Virology.

Huge Immune Response

The National Health and Medical Research Council (NHMRC) has awarded funding of almost $500,000 to refine the technique, called "Overlapping Peptide Pulsed Autologous Cells" (OPAL), so that it can be studied in humans.

“The ability to induce and expand the immune response across most or all parts of the virus is highly advantageous. Our results, which consistently demonstrated sharply enhanced immunity in vaccinated animals, suggest that this therapy could also work in humans,” the researchers report.

The team initially set out to develop a technique for measuring the effectiveness of an HIV vaccine. They first extracted blood from previously vaccinated animals and then coated the cells with HIV peptide markers (a technique which only takes an hour to complete).

In a normal situation, when HIV or any virus infects a cell, it leaves behind tell-tale markers, or peptides, on the cell surfaces that tell the immune system the cell is infected. In this study, the researchers did not infect the animals with HIV, but rather created the illusion to the body that these cells were infected because they had the tell-tale markers (peptides) on their surface.

When they injected this peptide-coated blood back into the vaccinated animals, they found that it triggered a huge immune response.

Human Testing Planned

“When we analysed HIV-specific immunity in the weeks following the assays (peptide-coating), a marked enhancement of virus-specific immunity was induced,” Associate Professor Kent says.

“The technique was also effective for boosting the immune response to Hepatitis C peptides, and we believe that it could be refined for many different viral infections and cancers. We have also shown it can be used to induce immune responses against drug resistant forms of HIV. The OPAL technique is simpler than current cell-based vaccine techniques, which usually require isolation of rare specialised cells from blood,”he adds.

The researchers plan to embark on a series of experiments to refine the technique to make it more practical and to generate bigger responses. They plan to begin human testing of the OPAL therapy in the next one to two years.

 


Terms of Membership for these forums
 

© 2014 Smart + Strong. All Rights Reserved.   terms of use and your privacy
Smart + Strong® is a registered trademark of CDM Publishing, LLC.